Bruker Announces Majority Acquisition of RECIPE
Bruker Corporation announced a majority investment in RECIPE to strengthen its clinical mass spectrometry capabilities.
Tag: acquisition
All
Latest
All
Latest
New Day Diagnostics Acquisition Agreement of Epigenomics AG Assets Gets Approved
New Day Diagnostics announced that the extraordinary general meeting of Epigenomics AG approved the acquisition agreement.
All
Latest
Enzo Biochem to Sell Clinical Laboratory to LabCorp
Enzo Biochem, has entered into an agreement for Labcorp to acquire the assets of Enzo’s clinical laboratory division, Enzo Clinical Labs.Â
CliniSys Expands Diagnostics Offering Through New Acquisition, Company Combination
CliniSys recently acquired HORIZON Lab Systems and combined with Sunquest Information Systems to embrace a new wave of digital diagnostics.
Read More
Co-Diagnostics Completes Acquisition for At-Home, Point-of-Care Platform
The acquisition is expected to streamline the commercialization of the company’s Eikon platform and YourTest PCR device as it nears completion.
Read More
BD Makes Acquisition to Expand Digital At-Home Testing
Global medical technology company BD has completed the acquisition of privately held Scanwell Health, a provider in smartphone-enabled at-home medical tests.
Read More
Quest Diagnostics Acquires Southern-Based Clinical Diagnostic Lab Provider
Quest Diagnostics acquired assets of an independent clinical diagnostic laboratory provider serving physicians and patients primarily in the South.
Read More
PerkinElmer Agrees to Acquire BioLegend
Upon joining PerkinElmer, BioLegend will expand PerkinElmer’s existing life science franchise into new segments, and its campus in San Diego will become PerkinElmer’s global Center of Excellence for research reagent content development for the combined company.
Read More
BD Envisions ‘One-Stick Hospital Stay’ via Velano Vascular Acquisition
BD has acquired Velano Vascular and its needle-free technology that enables high-quality blood draws from existing peripheral intravenous catheter (PIVC) lines to help eliminate multiple needlesticks for blood sample collection.
Read More
DiaSorin Completes Acquisition of Luminex Corporation
Through the acquisition, DiaSorin will gain access to Luminex’s multiplexing technology and a portfolio that will strengthen its existing offering.
Read More
Twist Bioscience Acquires iGenomX for $35M
Twist Bioscience Corporation has acquired iGenomX, which offers multiplex library preparation tools for NGS workflows.
Read More
Quest Diagnostics Completes Acquisition of Mercy’s Outreach Laboratory Services Business
Quest Diagnostics and Mercy announced that Quest has completed its acquisition of the outreach laboratory services business of Mercy.
Read More
Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
After its acquisition by Veracyte, HalioDx’s operations and laboratories will remain in Marseille, France and Richmond, Va.
Read More
Castle Biosciences to Acquire Myriad MyPath Laboratory
Castle Biosciences’ acquisition of CLIA-certified Myriad MyPath Laboratory from Myriad Genetics will expand its suite of genomic tests for skin cancer.
Read More
PerkinElmer to Acquire IVD Company Immunodiagnostic Systems Holdings
The acquisition will enable PerkinElmer to combine its channel expertise and testing capabilities with IDS’s chemiluminescence products in endocrinology, autoimmunity, and infectious diseases.
Read More
PerkinElmer Signs Agreement to Acquire Nexcelom Bioscience
Nexcelom is a global provider of automated cell counting instruments, image cytometry workstations, assays, and a variety of cell reagents and consumables.
Read More
New England Biolabs to Acquire Fluorogenics Limited
“The acquisition of FGL enables NEB to combine our expertise in enzyme manufacturing and assay development with their expertise in lyophilization, providing a complete solution for our customers,” says Jim Ellard, CEO of New England Biolabs.
Read More
Myriad Genetics to Sell Vectra Testing Business to Labcorp
Myriad Genetics has entered into a definitive agreement to sell select operating assets and intellectual property, including the Vectra test, from Myriad Autoimmune’s business unit to Labcorp for $150 million in cash.
Read More